Alcohol Use Disorder
📧 Sign up to get email alerts when something new happens for Alcohol Use Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-07-24Clinical Trial Update: Disulfiram as a Modulator of Amyloid Precursor Protein-processing
A completed clinical trial from Johannes Gutenberg University Mainz evaluated disulfiram as a modulator of amyloid precursor protein process…
-
CLINICAL_TRIALS trial_result · 2017-07-24Clinical Trial Update: A Comparative Effectiveness Trial of Optimal Patient-Centered Care [NA]
This clinical trial update reports the completion and results posting of a comparative effectiveness study evaluating an optimal patient-cen…
-
CLINICAL_TRIALS trial_result · 2017-07-14Clinical Trial Update: A Stage 2 Cognitive-behavioral Trial: Reduce Alcohol First in Kenya Intervention [Phase 1]
Phase 1 study update of a cognitive-behavioral intervention to reduce alcohol use in Kenya, including HIV-infected participants; status comp…
-
CLINICAL_TRIALS trial_result · 2017-07-12Clinical Trial Update: Study of an Emergency Department-based Intervention to Reduce Alcohol Misuse in Older Adults [NA]
This completed clinical trial (NCT02236494) evaluated an emergency department-based intervention to reduce alcohol misuse in older adults.
-
CLINICAL_TRIALS trial_result · 2017-07-06Clinical Trial Update: Risky Drinkers and the Web: a RCT Study in Region Friuli-Venezia Giulia. [NA]
A randomized controlled trial conducted in the Friuli-Venezia Giulia region evaluated web-based interventions for risky drinkers; the study …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Rimonabant to Reduce Alcohol Consumption [Phase 2]
Phase 2 clinical trial update for rimonabant aimed at reducing alcohol consumption, including healthy volunteers and individuals who drink a…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Single-dose of Nalmefene to Modulate Neural Alcohol Cue Reactivity [EARLY_Phase 1]
Phase 1 trial update evaluating a single dose of nalmefene to modulate neural responses to alcohol cues has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: The Effect of Naltrexone on Alcohol Craving and on Brain Activity During Alcohol Infusion [EARLY_Phase 1]
Early-phase trial evaluating whether naltrexone reduces alcohol craving and alters brain activity during alcohol infusion in individuals wit…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: The Stress-Hormone System in Alcohol-Dependent Subjects
This clinical trial update investigates how the body's stress-hormone system functions in individuals with alcohol use disorder. The study h…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Treatment of Patients With Alcoholism and Attention Deficit Disorder [Phase 4]
A Phase 4 clinical trial evaluating treatments for alcoholism and attention-deficit/hyperactivity disorder has completed.
-
CLINICAL_TRIALS trial_result · 2017-06-27Clinical Trial Update: Alcohol Interaction Study [Phase 1]
GlaxoSmithKline completed a Phase 1 alcohol interaction study in participants with alcohol use disorder.
-
CLINICAL_TRIALS trial_result · 2017-06-26Clinical Trial Update: Contingency Management to Reduce Alcohol Use in a Soup Kitchen Sample [NA]
A completed clinical trial evaluating contingency management as a behavioral intervention to reduce alcohol use in a soup kitchen population…
-
CLINICAL_TRIALS trial_result · 2017-06-16Clinical Trial Update: Naltrexone for Medication Compliance Among HIV-infected Men With Alcohol Use Disorder [Phase 4]
Phase 4 trial evaluating naltrexone to improve medication compliance in HIV-infected men with alcohol use disorder; the study has completed.
-
CLINICAL_TRIALS trial_result · 2017-06-16Clinical Trial Update: Personalized Drinking Feedback Interventions [NA]
A completed clinical trial evaluating personalized drinking feedback interventions for alcohol use disorder has finished. Sponsor: Universit…
-
CLINICAL_TRIALS trial_result · 2017-05-23Clinical Trial Update: Efficacy and Tolerability of Topiramate in Treatment of Bipolar Mania and Alcohol Use in Adolescents and Young Adults [Phase 4]
Phase 4 clinical trial evaluating the efficacy and tolerability of topiramate for bipolar mania and alcohol use in adolescents and young adu…
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Effectiveness of Bupropion for Smokers Recovering From Alcohol Dependence [Phase 3]
A Phase 3 trial evaluated the effectiveness of bupropion for smoking cessation in individuals recovering from alcohol dependence. The study …
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Naltrexone for At-Risk and Problem Drinking in Smoking Cessation Treatment [Phase 2]
Phase 2 trial evaluating naltrexone for individuals with hazardous drinking in a smoking-cessation program; results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-05-11Clinical Trial Update: Topiramate for the Treatment of Alcohol Dependent Binge-Eating Disordered Individuals [Phase 2]
Phase 2 trial results evaluating topiramate for individuals with alcohol use disorder and binge eating disorder have been completed; results…
-
CLINICAL_TRIALS trial_result · 2017-05-10Clinical Trial Update: To Evaluate the Influence of the A118G Polymorphism in the mu Opioid Receptor Gene (OPRM1) on Effects of GSK1521498 and Naltrexone on Physiological and Behavioural Markers of Brain Function in Healthy Social Drinkers [Phase 1]
A Phase 1 pharmacogenetic study evaluating whether the A118G polymorphism in OPRM1 influences physiological and behavioural effects of GSK15…
-
CLINICAL_TRIALS trial_result · 2017-05-10Clinical Trial Update: Computerized Alcohol Misuse Intervention System for Health Care [NA]
A completed clinical trial evaluating a computerized intervention system for reducing alcohol misuse in healthcare settings.
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: Double-blind Pilot Trial of Mirtazapine for the Treatment of Co-occurring AD/MDD. [Phase 2]
A double-blind Phase 2 pilot trial evaluated mirtazapine for co-occurring Major Depressive Disorder and Alcohol Use Disorder. The study has …
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: Preventing Alcohol Withdrawal With Oral Baclofen [Phase 2]
Phase 2 trial evaluated whether oral baclofen could prevent alcohol withdrawal in individuals with alcohol use disorder; the study was termi…
-
CLINICAL_TRIALS trial_result · 2017-04-27Clinical Trial Update: Treatment of Young Adults With Comorbid AUD/MDD: A Pilot Medication Trial [Phase 2]
A Phase 2 pilot trial evaluated a medication for young adults with comorbid major depressive disorder and alcohol use disorder; the study is…
-
CLINICAL_TRIALS trial_result · 2017-04-21Clinical Trial Update: Treatment for Alcoholism and Post-Traumatic Stress Disorder (Naltrexone) [Phase 4]
Phase 4 study evaluating naltrexone for alcohol use disorder (alcoholism/dependence) and comorbid post-traumatic stress disorder. Results ha…
-
CLINICAL_TRIALS trial_result · 2017-04-20Clinical Trial Update: Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone) [Phase 4]
This report notes the completion of a Phase 4 trial evaluating nicotine patch plus naltrexone for individuals with alcoholism and tobacco de…